Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

China flag China · Delayed Price · Currency is CNY
18.81
+0.02 (0.11%)
Apr 28, 2026, 3:05 PM CST
Market Cap21.18B +20.0%
Revenue (ttm)9.50B -17.8%
Net Income891.15M -14.0%
EPS0.77 -13.0%
Shares Out1.13B
PE Ratio24.28
Forward PE16.50
Dividend0.48 (2.53%)
Ex-Dividend DateApr 29, 2026
Volume11,774,977
Average Volume9,456,818
Open18.53
Previous Close18.79
Day's Range18.53 - 19.35
52-Week Range13.50 - 19.59
Beta0.38
RSI60.05
Earnings DateApr 21, 2026

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects;... [Read more]

Sector Healthcare
Founded 1989
Employees 6,787
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000739
Full Company Profile

Financial Performance

In 2025, SHE:000739's revenue was 9.78 billion, a decrease of -18.62% compared to the previous year's 12.02 billion. Earnings were 890.68 million, a decrease of -13.62%.

Financial Statements